Archives for October 2011

Adjuvant Endocrine Therapy plus Zoledronic Acid in Premenopausal Women

Zoledronic acid is a drug used to treat bone metastasis. Addition of Zoledronic acid to either tamoxifen or anastrozole increased disease-free survival by 36% compared with either tamoxifen or anastrozole alone. At a median follow-up of just under… [Learn More…]

Vemurafenib (PLX4032) for Metastatic Melanoma

PLX4032 is a next generation oral BRAF inhibitor for the treatment of melanoma. Data from the BRIM 2 clinical trial of previously untreated melanoma patients showed that  53% of the patients experienced tumor shrinkage compared with only 5% for… [Learn More…]